Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar;32(3):432-4.

[Clinical analysis of 17 cases of Gitelman syndrome]

[Article in Chinese]
Ling Qu  1 , Ting-Ting Zhang, Yi-Ming Mu
Affiliations
  • PMID: 22446001

[Clinical analysis of 17 cases of Gitelman syndrome]

[Article in Chinese]
Ling Qu et al. Nan Fang Yi Ke Da Xue Xue Bao. 2012 Mar.

Abstract

Objective: To analyze the clinical and laboratory characteristics of Gitelman syndrome.

Methods: Seventeen patients with Gitelman syndrome (male/female: 11/6) were analyzed for their clinical symptoms, laboratory test results, imaging findings, treatments and outcomes.

Results: Fifteen of the 17 patients presented with varying degrees of lower limb weakness, and 8 experienced flaccid paralysis. The laboratory tests showed hypokalemia (17/17), hypomagnesemia (17/17) and hypocalcemia (17/17). Blood renin activity (17/17), angiotensin II (14/17) and aldosterone levels (7/17) were significantly higher in the patients than in normal subjects. The symptoms were relieved by potassium alone or in combination with indomethacin, spironolactone and other potassium magnesium asparaginate, but the serum potassium and magnesium failed to recover the normal levels after the treatments.

Conclusion: The primary clinical manifestations of Gitelman syndrome are lower extremity weakness with hypokalemia and hypomagnesemia. Combined drug therapies including potassium, magnesium, aldosterone antagonists and other drugs are recommended. The prognosis of the patients is favorable.

PubMed Disclaimer

Publication types